Cardiac Safety Services Market

Cardiac Safety Services Market by Type, (Standalone, Integrated), Application (ECG Measurement, QT Study, Blood Pressure, Regulatory Expertise), by End User (Pharmaceutical, Biotech Companies, Contract Research Organization) - Global Forecast to 2023

Report Code: UC 1993 Jun, 2019, by marketsandmarkets.com
Heart is a frequent site of drug toxicity and assessing the safety of new drugs in in-vitro and in-vivo studies becomes crucial. Therefore, ensuring the safety of new medical entities is of paramount importance for the pharmaceutical industry. Cardiac safety concerns such as drug-induced heart rhythm abnormalities are among the key causes for promising drug failure or delay, causing loss of millions to the innovator or developer. This issue results in a lot of product recalls and pipeline attrition for pharmaceutical companies. To tackle these challenges and speed up development process, pharmaceutical companies are inclining towards the specialized service provider of cardiovascular safety studies.

 Table of Contents

1 Introduction
    1.1 Objectives of the Study 
    1.2 Market Definition 
    1.3 Market Scope 
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency 
    1.5 Limitations 
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Data 
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation 
    2.3 Market Breakdown and Data Triangulation 
    2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Driver
    5.3 Restraint
    5.4 Opportunity
    5.5 Challenges 

6 Cardiac Safety Service Market, By Technology
    6.1 Standalone
    6.2 Integrated

7 Cardiac Safety Service Market, By Technology
    7.1 ECG Measurements 
    7.2 QT Studies
    7.3 Blood Pressure 
    7.4 Cardiovascular Imaging
    7.5 Others (Protocol Design and Expert Reporting, Scientific & Regulatory Expertise)

8 Cardiac Safety Service Market, By Technology
    8.1 Pharmaceutical and Biotech Companies
    8.2 Cros
    8.3 Others (If Any)

9 Cardiac Safety Service Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe 
    9.4 Asia Pacific
    9.5 RoW

10 Competitive Landscape

11 Company Profile
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Covance Inc.
     11.2 Bioclinica 
     11.3 Celerion (US)
     11.4 Banook Group
     11.5 Ncardia
     11.6 Richmond Pharmacology
     11.7 Spaulding Clinical Research
     11.8 Biotrial
     11.9 Certara, L.P

Heart is a frequent site of drug toxicity and assessing the safety of new drugs in in-vitro and in-vivo studies becomes crucial. Therefore, ensuring the safety of new medical entities is of paramount importance for the pharmaceutical industry. Cardiac safety concerns such as drug-induced heart rhythm abnormalities are among the key causes for promising drug failure or delay, causing loss of millions to the innovator or developer. This issue results in a lot of product recalls and pipeline attrition for pharmaceutical companies. To tackle these challenges and speed up development process, pharmaceutical companies are inclining towards the specialized service provider of cardiovascular safety studies.

Increasing focus on of drug discovery and development, stringent regulatory guidelines for cardiac safety in drugs development and unavailability of cardiac safety experts in-house are some of the key factors driving the growth of this market. However, current cardiac safety platforms and services have several limitations and there remains persistent unmet need to improve the predictive power of present cardiac drug safety platforms and services. Hence, more accurate predictive models are needed and this holds and enormous opportunity for the players in this market.

The cardiac safety services market is segmented based on type, application, end user, and region. The cardiac safety services can either be integrated or standalone.  Their applications include ECG measurement, QT studies, blood Pressure, cardiovascular Imaging and Others. Other applications include protocol design and expert reporting, scientific & regulatory expertise. Similarly, the key users for cardiac safety services includes pharmaceutical and biotechnology companies and contract research organizations.

The market by region is divided in four key geographies - North America, Europe, Asia-Pacific and rest of the World. North America is expected to dominate the market in 2018, with the US accounting for a major share. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period.

Key companies operating in this space include Covance Inc. (US), Bioclinica (US), ERT Clinical (US), Celerion (US), BANOOK GROUP (France), Ncardia (Belgium), Richmond Pharmacology (UK), Spaulding Clinical Research (US), Biotrial (US) and Certara, L.P (US)

Report Code
UC 1993
Published ON
Jun, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cardiac Safety Services Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home